Kristine M. Ball
At a glance: Kristine M. Ball is Director at Oruka Therapeutics (ORKA). Their latest SEC Form 4, filed Nov 13, 2026, reported a sale of $122K. On file: 0 purchase lines ($0) and 6 sale lines ($1.9M).
Director at Oruka Therapeutics, Inc. (ORKA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 13 NewSEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 1,19616,804 held (−7%) | $102.10 | $122K | +3.2% |
| Nov 13 NewSEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 1,30015,504 held (−8%) | $103.09 | $134K | +2.2% |
| Nov 13 NewSEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 2,03913,465 held (−13%) | $104.16 | $212K | +1.1% |
| Nov 13 NewSEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 10,7652,700 held (−80%) | $105.31 | $1.1M | +0.0% |
| Nov 13 NewSEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 2,500200 held (−93%) | $106.05 | $265K | -0.7% |
| Nov 13 NewSEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 200 | $106.98 | $21K | -1.5% |
- Sell
Director Kristine M Ball sold $122K of ORKA at $102.10 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Kristine M Ball sold $134K of ORKA at $103.09 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Kristine M Ball sold $212K of ORKA at $104.16 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Kristine M Ball sold $1.1M of ORKA at $105.31 — cuts the stake by 80%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Kristine M Ball sold $265K of ORKA at $106.05 — cuts the stake by 93%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Kristine M Ball sold $21K of ORKA at $106.98 — pre-scheduled 10b5-1 plan sale.
Follow Kristine M. Ball
Get one email when Kristine M. Ball files a new purchase or sale. Free.
At most one email a day about Kristine M. Ball, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.